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Conclusion: Besides of inducing a slight inﬂammatory response, mi-
tochondrial respiratory activity dysfunction signiﬁcantly potentiates the
cytokine-induced inﬂammatory response in synoviocytes in relation with
PGE2 and IL-8 release, via ROS production and NF-kB activation, con-
tributing to chronic inﬂammation of synovial tissue in RA and aging joint.
Resveratrol, a natural antioxidant, must be taken into account as a potential
preventive or therapeutic agent in such conditions.
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PTH IMPROVES SYNOVITIS IN AN EXPERIMENTAL MODEL OF
OSTEOARTHRITIS PRECEDED BY OSTEOPOROSIS
L. Lugo1, M. Bellido1, O. Sánchez-Pernaute1, J. Roman-Blas1, S. Castañeda2,
R. Largo1, G. Herrero-Beaumont1
1Fundacion Jimenez Diaz, Madrid, Spain; 2Hosp. de la Princesa, Madrid, Spain
Purpose: Synovitis is a major component of OA, contributing to both
patient symptoms and progression of cartilage damage. Intermittent PTH
administration is associated with a decrease in musculoskeletal pain in
osteoporosis patients. We have already observed that PTH prevents pro-
gression of cartilage damage by improving subchondral bone quality in
experimental osteoarthritis preceded by osteoporosis in rabbits. In this
study, we aimed to characterize the main histopathological features of syn-
ovitis compromise in our combined animal model, as well as to determine
whether intermittent administration of PTH could decrease the synovial
inﬂammatory response.
Methods: OP was induced in 14 (8 month-old; 3.5-4.8 kg body weight),
skeletally mature female NZ rabbits, by ovariectomy (OVX) and intramuscu-
lar injections of methylprednisolone 1 mg/kg/day for 4 weeks (OP group).
Ten age and gender-matched additional animals were used as controls
(Healthy group). Surgical OA was simultaneously induced in the left knees
of all the rabbits (OA and OPOA groups). Twelve weeks after OVX, iPTH
(1-34) was s.c. administered to 6 OP rabbits (40 μg/day, 5 days/week) for
10 wks; right knees: OP+PTH group; left knees: OPOA+PTH group). All the
animals were sacriﬁced 22 weeks after OVX. The synovium was analyzed by
Krenn grading of chronic synovitis and immunohistochemically for RAM11
and T lymphocytes. ARN was isolated to perform quantitative RT-PCR for
type I collagen. Articular cartilage damage was assessed by Mankin’score.
Nonpair-wise statistical comparisons were done using Mann-Whitney test
for the different variables studied and the correlations were performed
with Spearman test (SPSS v. 15).
Results: There was a positive and signiﬁcant correlation between the
Mankin and the Krenn scores (r=0,473, p=0,035). The synovitis score was
similar for OA or OPOA groups, however it was signiﬁcant reduced in
OPOA+PTH vs OPOA group (p<0.05). Regarding the histopathology, both,
OA and OPOA showed an increase of hyperplasia, synovial stroma acti-
vation and inﬂammation (p<0.05). But, there was no difference between
OA and OPOA groups in any outcome. Nevertheless, PTH treatment re-
duced signiﬁcantly hyperplasia and synovial activation. Respect to RAM11
expression, we observed a tendency to rise in OA and OPOA vs Healthy,
but PTH treatment does not affect the expression of RAM11. No presence
for T limphocytes was detected in any case. Type I collagen expression in
synovium was increased in OA and OPOA (p<0.05) and reduced after PTH
treatment (p<0.05).
Conclusions: In our model of OA aggravated by previous OP, synovitis
correlated with OA cartilage damage. OPOA synovitis is characterized by
hyperplasia and synovial stroma activation and in a lesser extent by
inﬂammatory inﬁltrates. Intermittent administration of PTH succeeded in
improving the synovitis, by ameliorating both hyperplasia and ﬁbrosis.
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IF1 AND BETA SUBUNITS ARE PRESENT ON THE EXTERNAL SURFACE OF
CULTURED HUMANMENISCI AND CARTILAGE CELLS
R. Aguilar-Gaytán1, C. Jiménez-Díaz1, M. Tuena de Gómez-Puyou2,
C. Ibarra-Ponce de León1
1Natl. Inst. of Rehabilitation, Mexico, City, Mexico; 2Cellular Physiology Inst.,
UNAM., Mexico, City, Mexico
Purpose: The F1-F0-ATP synthase is an enzyme complex responsible for ATP
synthesis in the mitochondrial inner membrane and is driven by oxidative
phosphorylation. In the last years several reports have shown that some
subunits as inhibitory protein (IF1) localize in the plasma membrane of
neoplasic, endothelial, tumor cells, keratinocytes and hepatic. It has been
shown that α and β subunits bind angiostatin on cell surface of endothelial
cells (EC) and mediate down-regulation of endothelial cell proliferation and
migration. Some data suggests that angiostatin inhibits vascularization by
suppression of endothelial ATP metabolism, which, in turn, may regulate
vascular physiology. The angiostatin blocks synthesis and hydrolysis of ATP
on the surface of endothelial cells as well as EC differentiation to form
tubes and IF1 did not. IF1 does not have the anti-angiogenic effect of
angiostatin, but it may attenuate the anti-angiogenic response to angio-
statin. Osteoarthritis (OA) is a disorder of articular cartilage characterized
by degeneration, increased cell proliferation, proteinases, growth factors,
cytokines, inﬂammatory mediators and vascularization known as vascular
pathology. At this moment, no evidence about the ectopic presence of these
subunits of ATP synthase on the surface of osteoarthritic chondrocytes.
Therefore we studied the dentiﬁcation of the ectopic presence of IF1 and
β subunits on the membrane surface of human menisci and cartilage
cells.
Methods: The identiﬁcation of the IF1 and β subunits of ATP synthase were
using ﬂow cytometry and immunoﬂuorescence detection on cultured hu-
man menisci (vascular region) and cartilage (avascular) cells, using speciﬁc
antibodies. The tissues were obtained during surgery of the patients and
digested with collagenase II and cultured under 5% CO2 and 37°C.
Results: Human menisci and cartilage cells were incubated with speciﬁc
antibodies against IF1 and β subunits to show a plasma membrane location.
Histograms of ﬂow cytometry data show the increase ﬂuorescence relative
to that observed when only the secondary antibody was used. These results
were corroborated by ﬂuorescent microscopy using the same antibodies.
Conclusions: We showed that the surface membranes of cultured human
chondrocytes and ﬁbrochondrocytes contain the IF1 and β subunits of ATP
synthase. We have to deﬁne if angiostatin is able to bind on ATP synthase
and modulate angiogenesis.
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ANGIOGENESIS IN SUBCHONDRAL BONES OF OSTEOARTHRITIC KNEES
R. Akagi, M. Saito, N. Ikegawa, S. Yamaguchi, K. Matsuki, S. Sato,
K. Nakagawa, K. Takahashi, T. Sasho
Chiba Univ. Hosp., Chiba, Japan
Purpose: Angiogenesis is implicated as a cause of many diseases as well as
inevitable repair process. In osteoarthritic (OA) knees, pathological changes
in the subchondral bone were considered to be related to disease initiation,
progression, and a potent source of knee pain. Our previous study revealed
positive immunoreactivity of Substance P, Cox-2, TNF-α, and TUJ1 in cystic
lesions formed in the subchondral bone of affected compartments. These
cystic lesions consist of several types of cells including CD-34 positive vas-
cular endothelial cells. This implicates up-regulated angiogenetic activities
of affected compartments. Using specimens derived at the time of total
knee arthropasty (TKA) for medial-type OA knees, histological examination
revealed elevated vascularity in the subcondral bone of the medial femoral
condyle (MFC) compared with that of the lateral femoral condyle (LFC). In
this study we investigated the relationship between angiogenetic activities
of subchondral bone in OA knees and the extent of degeneration overlaying
the subchondral bone.
Methods: Among patients who received total knee arthroplasty (TKA)
in our institution, 7 patients with medial-type OA knees (one male, six
female) with minimum involvement of lateral compartment conﬁrmed
with lack of bone marrow edema on Magnetic Resonance Imaging as well
as macroscopic examination were selected. The mean age was 73.5 years,
and every patient was classiﬁed as grade IV according to the Kellgren
and Lawrence scale.Subchondral bone of the weight bearing compartment
of MFC, LFC, and the anterior non-weight bearing compartment of distal
femur (AF) were obtained at the time of TKA. Specimens were cultured
in Dulbecco’s Modiﬁed Eagle Medium with 7% Fetal Bovine Serum for
2 weeks. The culture supernatant was then added to the angiogenesis
kit (KURABO, Osaka Japan) and cultured for another 11 days until vessel
lumens were formed. Primary antibody against CD 31 and secondary
antibody of Goat anti-mouse IgG AlkP conjugate were used to stain the
vessels. The length, area, number of joints and paths of the vessels were
analyzed automatically by Angiogenesis Image Analyzer (KURABO, Osaka
Japan) for each compartment.
Results: The degrees of angiogenesis assessed by the four parameters have
a tendency to be higher in the MFC compared to the LFC and the AF, but it
did not reach statistical signiﬁcance (Figs. 1–4).
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Figure 1 Figure 2
Figure 3 Figure 4
Conclusions: Several previous studies reported that formation of new
blood vessels in the subchondral bone was related with degeneration of
articular cartilage. In this study, no signiﬁcant differences were elucidated
in the angiogenesis of subchondral bone using supernatant from explants
culture, despite the fact that signiﬁcant differences was found in histolog-
ical examination. The angiogenesis of subchondral bone may be a slowly
progressive process, as well as the progression of knee OA, and it is possible
that the peak of this process was not detected in this study.
Animal models
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“ALARMINS” S100A8 AND A9 ARE ACTIVELY INVOLVED IN REGULATION
OF CARTILAGE DESTRUCTION DURING OSTEOARTHRITIS
P. van Lent1, A. Blom1, R. Schelbergen1, A. Sloetjes1, T. Vogl2, J. Roth2,
W. van den Berg1
1Radboud Univ. Med. Ctr., Nijmegen, Netherlands; 2Immunology UKM,
Muenster, Germany
Purpose: Prominent proteins released by activated macrophages are the
“alarmins” S100 A8 and A9. Both proteins accumulate in inﬂammatory
synovial ﬂuids (up to 50 μg/ml) and have been postulated to be involved
in the pathogenesis of rheumatic diseases like RA. S100A8 is assumed
to be the active component whereas S100A9 functions as the regulatory
subunit preventing S100A8 from degradation. The aim is to study the active
involvement of S100A8/A9 in cartilage destruction in two murine models
of osteoarthritis.
Methods: Experimental OA was either induced by injection of collagenase
into murine knee joints, which causes local instability or by transsection of
the medial anterior meniscotibial ligament which leads to destabilisation
of the medial meniscus (DMM). OA phenotypes were studied within 8
weeks after induction. Collagenase-induced-osteoarthritis involves chronic
synovial activation in contrast to DMM. Synovial expression of mRNA and
protein levels of S100A8 and S100A9 during the course of osteoarthritis was
performed by using RT-PCR and immunolocalisation. Both models were
induced in S100A9 deﬁcient mice (myeloid cells also lack S100A8 at the
protein level). Synovial activation and cartilage destruction was measured
by histology. Cartilage pathology was scored in a blinded way using an ar-
bitrary score that considered both grade (0-6) and stage (0-5) of pathology.
Primary murine chondrocytes were stimulated with rS100A8,rS100A9 and
S100A8/S100A9 complex.
Results: Kinetic studies show that mRNA levels of S100A8 and S100A9
were strongly elevated in synovium during the course of collagenase-
induced osteoarthritis (at day 7 between 20-35 fold and day 21 between
30-65 fold). In contrast, cytokine expression like IL-1 was already low at
day 7. Expression of S100A8 and S100A9 protein nicely correlated with
thickening of the synovial lining layer and were localized particularly in
activated macrophages. In contrast, in the mechanically induced DMM
model, marginal expression of both proteins was seen, only evident at
day 7 after induction and consistent with limited synovial thickening. Of
interest, particularly the active form of S100A8 was expressed in chon-
drocytes of cartilage areas in which lesions preferentially developed at
later time-points. When collagenase-induced-osteoarthritis was elicited in
S100A9-/- mice, signiﬁcantly lower synovial activation was observed when
compared to WT mice. Synovial activation was 62% lower at day 42. In
addition, cartilage destruction was measured in various cartilage surfaces
(medial and lateral tibia and femur) of the knee joint. Cartilage destruction
was strongly and signiﬁcantly lower in all surfaces and ranged from a
45% reduction in the lateral tibia to 73% reduction in the medial femur.
In vitro, S100A8 stimulated primary chondrocytes to upregulate MMPs
particularly MMP-3 (64 fold increase). S100A9 and S100A8/A9 complex
were less effective. In contrast, in the DMM model, where S100A8 was
hardly expressed in the synovium, no differences in cartilage destruction
were observed in S100A9-/- and WT mice.
Conclusions: Alarmins S100A8/A9 play a crucial role in cartilage destruc-
tion in an osteoarthritis model that shows clear synovial involvement.
S100A8/A9 expression in the synovium causes pathology probably by
stimulating MMP-mediated damage in the cartilage matrix.
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INHIBITION OF TRANSFORMING GROWTH FACTOR ALPHA SIGNALING
SLOWS PROGRESSION OF OSTEOARTHRITIS
S.E. Usmani1, T.C. Appleton1, I.D. Welch2, T.L. Hill2, J.S. Mort3, F. Beier1
1Dept. of Physiology and Pharmacology, The Univ. of Western Ontario, London,
ON, Canada; 2Dept. of Animal Care and Vet. Services, The Univ. of Western
Ontario, London, ON, Canada; 3Shriner’s Hosp., McGill Univ., Montreal, QC,
Canada
Purpose: No cures currently exist for the degenerative joint disease os-
teoarthritis (OA). Furthermore, the complex and multi-variable nature of
OA continues to challenge the development of effective therapies. In an
attempt to identify potential targets for disease modifying osteoarthritis
drugs (DMOADs), our lab recently established a surgical model of OA to
study gene expression changes in degenerating cartilage. Transforming
growth factor alpha (TGFα) gene expression was upregulated in our model
and further in vitro studies showed that TGFα suppressed chondrocyte
expression of anabolic factors aggrecan and type II collagen and increased
expression of the catabolic factor matrix metalloproteinase 13 (MMP13).
We thus identiﬁed TGFα as a novel therapeutic OA target. The purpose of
this project is to examine the role of TGFα and its receptor, the epidermal
growth factor receptor (EGFR), in the development of OA in vivo. We
hypothesize that inhibition of TGFα signaling will delay disease progression
in surgical OA models.
Methods: Adult male Sprague Dawley rats underwent anterior cruciate
ligament transection and partial medial menisectomy (OA surgery) or sham
surgery. All animals were subjected to forced mobilization of their joints
three times a week. Furthermore, animals received local administration
of either the EGFR inhibitor AG1478 or vehicle via mini drug pumps. At
0, 4, 7 and 10 weeks post-surgery, animals were sacriﬁced, knee joint
histopathology was scored and blood samples were collected to analyze
biomarkers for type II collagen breakdown and synthesis. In addition, adult
male Tgfa null mice and control littermates received either meniscotibial
transection (MTX) or sham surgery. At 7 weeks post-surgery knee joint
histopathology was scored and tissues were immunostained for disease
markers. Since some features of cartilage and bone development are known
to be recapitulated during the disease process, skeletal development in Tgfa
null mice was also examined.
Results: Rats that received OA surgery plus AG1478 had signiﬁcantly lower
OARSI scores than those that received OA surgery plus vehicle at 4 and 7
weeks. Biomarker analysis showed that EGFR inhibition results in greater
type II collagen synthesis and decreases collagen degradation during early
time points. MTX surgery produced mild OA in mice after 7 weeks.
Tgfa null mice had lower OARSI scores and expressed less MMP13 and
type II collagen neoepitopes than their control littermates. Tgfa null mice
also showed transient growth retardation after birth. Histological analyses
demonstrated a wider hypertrophic zone of the growth plate. TRAP staining
showed a decrease in osteoclasts at the cartilage-bone interface, suggesting
that removal of hypertrophic cartilage is delayed. These phenotypes are
absent in adult mice.
Conclusions: TGFα signaling plays an important role in osteoarthritis pro-
gression in vivo and should be investigated further as a potential target for
DMOAD development.
